Who owns ASND
267 institutions reported holding ASND for 2026Q1, together 103% of the company, fewer than the 298 a quarter earlier.
267
Institutions reporting a position · as of 2026Q1 · down from 298 the quarter before
- Shares held by institutions
- 62.6M
Shares held by institutions · 103% of the company · long US equity positions only, as reported on Form 13F
- Reported value
- $14.3B
Reported value · at 2026-03-31 prices, not today's
- Top 5 holders
- 50%
Top 5 holders · of the whole company, between five filers
Details›
- Reporting quarter2026-03-31
- 2026Q1
- Quarters on record
- 45
- New positions
- 34
- Positions exited
- 65
- Added to
- 100
- Reduced
- 98
- Top 10 holdersof the company
- 68%
| Quarter | Filers | Shares | Reported value |
|---|---|---|---|
| 2026Q1 | 267 | 62.6M | $14.3B |
| 2025Q4 | 298 | 64.7M | $13.8B |
| 2025Q3 | 276 | 63.8M | $12.7B |
| 2025Q2 | 244 | 62.9M | $10.9B |
| 2025Q1 | 241 | 65.2M | $10.1B |
| 2024Q4 | 213 | 63.7M | $8.78B |
| 2024Q3 | 217 | 62.6M | $9.31B |
| 2024Q2 | 202 | 60.7M | $8.28B |
| 2024Q1 | 188 | 60.8M | $9.19B |
| 2023Q4 | 184 | 60.3M | $7.59B |
| 2023Q3 | 159 | 60.3M | $5.64B |
| 2023Q2 | 157 | 61.0M | $5.45B |
| 2023Q1 | 164 | 61.0M | $6.54B |
| 2022Q4 | 185 | 65.9M | $8.05B |
| 2022Q3 | 182 | 66.7M | $6.89B |
| 2022Q2 | 167 | 63.2M | $5.88B |
| Holder | Shares | % of company | Value |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 10.3M | 17% | $2.35B |
| T. Rowe Price Investment Management, Inc. | 6.2M | 10% | $1.41B |
| Avoro Capital Advisors LLC | 5.1M | 8.3% | $1.16B |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 4.8M | 7.9% | $1.10B |
| FMR LLC | 3.9M | 6.4% | $887M |
| Artisan Partners Limited Partnership | 3.2M | 5.3% | $739M |
| FRANKLIN RESOURCES INC | 2.1M | 3.4% | $469M |
| Capital International Investors | 2.0M | 3.2% | $448M |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 1.9M | 3.1% | $426M |
| WELLINGTON MANAGEMENT GROUP LLP | 1.8M | 2.9% | $402M |
SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.
reading the register…
Biotechnology
Ranks #59 of 145 by Smart Score